The Fidelity Dividend ETF for Rising Rates (FDRR) is a passively managed, index-tracking exchange-traded fund that seeks returns corresponding to the Fidelity Dividend Index for Rising Rates. The underlying index selects large- and mid-capitalization dividend-paying companies that are expected to sustain and grow their payouts while exhibiting a positive correlation to increases in 10-year U.S. Treasury yields.
The portfolio holds roughly 126 securities, with a pronounced emphasis on large-cap names. Its largest holdings include NVIDIA, Apple, Microsoft, Alphabet, Dell Technologies, Broadcom, Meta Platforms, Eli Lilly, JPMorgan Chase, and Cisco Systems. By sector, technology leads at roughly 38% of assets, followed by financials (about 12%), health care (about 10%), communication services (about 9%), and industrials (about 8%). U.S. equities represent the overwhelming majority of exposure. When assessing sector weightings like these, I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The fund's net expense ratio is 0.15%, and assets under management (AUM) are approximately $750 million. This structure explains why FDRR behaves less like a traditional high-dividend income fund and more like a diversified large-cap equity portfolio with a meaningful growth and technology tilt.
FDRR operates at the intersection of two themes that do not always move together: dividend income and sensitivity to interest rates. The index's screening methodology favors companies whose returns historically rise alongside 10-year Treasury yields, which tends to reward financials, select energy and industrial names, and large cash-generating technology firms that initiate or grow dividends.
The broader macro backdrop has been defined by a relatively stable-to-modestly higher rate environment, persistent but cooling inflationary pressures, and a market that has favored a narrow group of megacap technology and artificial intelligence (AI) leaders. This concentration has supported the fund's technology-heavy sleeve while muting the contribution from more traditionally defensive dividend sectors such as utilities and consumer staples. The fund's "rising rates" emphasis means its sensitivity to shifts in Treasury yields remains a defining feature of both its risk and its return profile. From what I see, this dynamic makes ongoing yield monitoring essential.
Over the most recent 30-day window, FDRR declined roughly 2%, while over the trailing quarter the fund was down about 1.8% on a price basis. This pattern reflects a range-bound, low-volatility grind rather than a sharp directional move, with the fund's beta of roughly 0.89 keeping swings somewhat contained relative to the broad market.
The performance has been closely tied to its largest holdings. Strength in large semiconductor and mega-cap technology names has provided ballast, while any pullback in those concentrated positions has weighed disproportionately on the fund given technology's near-40% weight. Financials and health care have contributed a steadier, more defensive influence. The dividend yield of about 2% continues to provide a modest income cushion, and the fund's quarterly distribution schedule reinforces its dual identity as both an income vehicle and a large-cap equity allocation. I’m watching this closely because the yield and sector balance could shift with any sustained move in rates.
Looking across 2026, the most important structural factors for FDRR are the trajectory of long-term Treasury yields, the durability of megacap technology earnings, and the pace of any broadening in market leadership. Because the fund is explicitly built around a positive correlation to rising 10-year yields, a sustained move higher in rates would tend to support its financials and rate-sensitive holdings, while a decline in yields could favor its more growth-oriented technology sleeve.
Investors should also monitor the earnings cycle of the fund's largest technology positions, which account for a substantial share of total return, as well as dividend growth across financials and health care. Policy developments, inflation trends, and shifts in institutional capital flows between growth and value styles are additional factors likely to shape the fund's behavior. Risks include concentration in technology, sensitivity to interest-rate surprises, and the possibility that a narrow leadership regime persists. These themes, rather than any single data point, are likely to define FDRR's performance over the coming months.
In my own research process, Tickeron’s AI Screener has become a practical way to scan for momentum across sectors and individual holdings. It applies technical indicators, fundamentals, volatility measures, and AI-generated signals to surface opportunities that might otherwise require manual effort. For funds like FDRR, this kind of quantitative layer helps clarify which themes are gaining or losing traction without replacing traditional due diligence.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
FDRR saw its Momentum Indicator move below the 0 level on October 30, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 70 similar instances where the indicator turned negative. In 54 of the 70 cases, the stock moved further down in the following days. The odds of a decline are at 77%.
The Moving Average Convergence Divergence Histogram (MACD) for FDRR turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 34 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
FDRR moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for FDRR crossed bearishly below the 50-day moving average on October 26, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 54%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FDRR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for FDRR entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 54 cases where FDRR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where FDRR advanced for three days, in 301 of 357 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
FDRR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows